Former human services minister Michael Keenan is keeping a low profile. Or, at least, as low as possible, given a whole chapter is devoted to his conduct in the just-released robo-debt royal commission.
Imagine our surprise, then, to see him pop up on the ASX, having been appointed on Tuesday to the board of $12 million Singapore-based biotech Osteopore (as first noted by trade title Biotech Daily).
Loading...
Myriam Robin is Rear Window editor based in the Melbourne newsroom. A Rear Window columnist since 2017, she previously reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
